Evodiamine can decrease the neurotoxicity of tau aggregation and exhibit a neuroprotective effect. Our results demonstrate that evodiamine has a therapeutic potential for AD treatment.
No takes yet. Share an insight, caveat, or question.
Chou et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: